Nonetheless, our off-the-records analysis on non-naïve patients, who were treated with doses as high as 8 units ONA and 30 units of ABO per injection point (lateral and medial upper eyelid), was not related to ptosis or diplopia. This evidence concerns the gene ABO and eye disorder.